Clinical Trial

Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this exploratory clinical trial is to apply Unreal Engine 5 (UE5)-based Mixed Reality (MR) technology to achieve real-time stereoscopic visualization of surgical planning, personalized free flap harvest and defect reconstruction, accurate oral cancer resection, and precise morphological and volumetric matching of the reconstructed free flap to the defect site. Researchers adopted a parallel controlled design, with participants randomized into three groups: Experimental Group 1 (undergoing Mixed Reality \[MR\] technology-assisted surgery), Experimental Group 2 (undergoing virtual surgical guide-assisted surgery), and Control Group (undergoing conventional surgery). A total of 30 participants will be recruited, with 10 cases in each group. The primary purpose is to confirm the effectiveness of MR technology in assisting oral cancer resection, free flap design, harvest, and defect reconstruction. Allocation concealment will be implemented via the sealed envelope method.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-07.
Trial Details
NCT Number NCT07466810
Lead Sponsor Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Conditions Tongue Squamous Cell Carcinoma, Mixed Reality, Virtual Surgical Planning, Free Flap, Oral Cancer
Enrollment 30 participants
Start Date 2026-04-01
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-20